CIK 0001621221 · Non-accelerated filer<br>Smaller reporting company
ARTELO BIOSCIENCES, INC.
Sign in to watch- Ticker
- ARTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 331220924
- Phone
- 858-925-7049
- Business address
- 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA, 92075
- Former names
- REACTIVE MEDICAL INC., KNIGHT KNOX DEVELOPMENT CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-17 | MATSUI CONNIE Director | Grant or award · Stock Option (right to buy) | +136 | 136 | ||
| 2026-07-17 | Blayney Douglas Director | Grant or award · Stock Option (right to buy) | +136 | 136 | ||
| 2026-07-17 | Reyes Gregory Director | Grant or award · Stock Option (right to buy) | +136 | 136 | ||
| 2026-07-17 | EMANUELE ROBERT MARTIN Director | Grant or award · Stock Option (right to buy) 10b5-1 | +136 | 136 | ||
| 2026-07-17 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +136 | 136 | ||
| 2026-07-17 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +136 | 136 | ||
| 2026-01-30 | MATSUI CONNIE Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-30 | Blayney Douglas Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-30 | EMANUELE ROBERT MARTIN Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-30 | Kelly Steven Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-30 | FAVORITO TAMARA A Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-30 | Reyes Gregory Director | Grant or award · Stock Options (right to buy) | +292 | 292 | ||
| 2026-01-29 | Spring Mark Edward Chief Financial Officer | Grant or award · Stock Options (right to buy) | +36,391 | 36,391 | ||
| 2026-01-29 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Grant or award · Stock Options (right to buy) | +154,713 | 154,713 | ||
| 2025-10-28 | MATSUI CONNIE Director | Conversion · Convertible Promissory Note | −0 | $140,000.00 | $0 | |
| 2025-10-28 | MATSUI CONNIE Director | Conversion · Warrant (right to buy) | +38,346 | 38,346 | ||
| 2025-10-28 | MATSUI CONNIE Director | Conversion · Warrant (right to buy) | +70,376 | 70,376 | ||
| 2025-10-28 | MATSUI CONNIE Director | Conversion · Convertible Promissory Note | +0 | $110,843.00 | $0 | |
| 2025-10-28 | FAVORITO TAMARA A Director | Conversion · Convertible Promissory Note | −0 | $25,000.00 | $0 | |
| 2025-10-28 | FAVORITO TAMARA A Director | Conversion · Warrant (right to buy) | +6,846 | 6,846 |
Page 1 of 9 · 176 trades